Growth Metrics

Eli Lilly (LLY) Enterprise Value (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.33%
Dec 31, 2025 26.26%
Sep 30, 2025 -184.05%
Jun 30, 2025 -10.55%
Mar 31, 2025 6.12%
Dec 31, 2024 2.75%
Sep 30, 2024 -4.47%
Jun 30, 2024 -31.56%
Mar 31, 2024 11.81%
Dec 31, 2023 -17.82%
Sep 30, 2023 12.27%
Jun 30, 2023 23.04%
Mar 31, 2023 -70.88%
Dec 31, 2022 21.17%
Sep 30, 2022 -0.92%
Jun 30, 2022 -7.60%
Mar 31, 2022 34.71%
Dec 31, 2021 -2.89%
Sep 30, 2021 -18.88%
Jun 30, 2021 -7.06%
Mar 31, 2021 18.50%
Dec 31, 2020 -1.05%
Sep 30, 2020 -56.70%
Jun 30, 2020 -33.14%
Mar 31, 2020 29.29%
Dec 31, 2019 -49.14%
Sep 30, 2019 31.33%
Jun 30, 2019 -11.63%
Mar 31, 2019 70.71%
Dec 31, 2018 12.00%
Sep 30, 2018 -16.33%
Jun 30, 2018 -44.73%
Mar 31, 2018 40.58%
Dec 31, 2017 -15.80%
Sep 30, 2017 -28.10%
Jun 30, 2017 -56.29%
Mar 31, 2017 42.46%
Dec 31, 2016 -42.04%
Sep 30, 2016 -7.26%
Jun 30, 2016 -31.60%
Mar 31, 2016 32.88%
Dec 31, 2015 -3.10%
Sep 30, 2015 -2.48%
Jun 30, 2015 -2.01%
Mar 31, 2015 14.53%
Dec 31, 2014 -0.32%
Sep 30, 2014 6.23%
Jun 30, 2014 1.66%
Mar 31, 2014 3.46%
Dec 31, 2013 -0.33%
Sep 30, 2013 -14.21%
Jun 30, 2013 0.50%
Mar 31, 2013 16.74%
Dec 31, 2012 17.83%
Sep 30, 2012 -31.22%
Jun 30, 2012 -6.64%
Mar 31, 2012 28.50%
Dec 31, 2011 -1.71%
Sep 30, 2011 -7.23%
Jun 30, 2011 5.77%
Mar 31, 2011 0.26%
Dec 31, 2010 -9.55%
Sep 30, 2010 -18.16%
Jun 30, 2010 -9.40%
Mar 31, 2010 -5.78%
Dec 31, 2009 -14.43%
Sep 30, 2009 -12.47%
Jun 30, 2009 -5.45%